Grace F, Sculthorpe N, Baker J, Davies B
Centre for Ergogenic Drugs Research, School of Applied Sciences, University of Glamorgan, Pontyridd, Wales, UK.
J Sci Med Sport. 2003 Sep;6(3):307-12. doi: 10.1016/s1440-2440(03)80024-5.
The literature regarding the blood pressure response to AAS use is equivocal. In addition, there is currently little data available on the Rate Pressure Product (RPP) response to anabolic androgenic steroids (AAS) use. The experimental aim of this study was to investigate the effects of AAS administration in combination with resistance training on blood pressure and rate pressure product in male amateur bodybuilders and compare the results with a morphologically matched, resistance trained control group. Subjects were divided into two groups (n=16 AAS users; n=16 controls). Systolic and Diastolic Blood Pressure, RPP. Resting Heart Rate and Body Composition measurements were obtained before (Pre), during (During) and 6-8 weeks following (Post) the AAS cycle in the AAS users with similar time intervals for the control group. No significant cardiovascular or morphological changes in the control group were found throughout the study. Significant increases in both diastolic (P<0.01) and mean arterial blood pressures (P<0.05) were found from Pre to Post cycle in the AAS group. RPP also increased significantly (P<0.01) from pre to post AAS cycle. All cardiovascular parameters returned to normal baseline measurements between 6 and 8 weeks post cycle. No blood pressure measurements throughout the study were consistent with clinically defined hypertension. The findings indicate that the AAS group exhibited significant increases in standard cardiovascular measurements compared with the control bodybuilders, and provides a contraindication to AAS use especially in borderline hypertensives.
关于使用促合成代谢雄激素类固醇(AAS)对血压影响的文献尚无定论。此外,目前关于心率血压乘积(RPP)对使用AAS反应的数据也很少。本研究的实验目的是调查AAS联合抗阻训练对男性业余健美运动员血压和心率血压乘积的影响,并将结果与形态学匹配的抗阻训练对照组进行比较。受试者分为两组(n = 16名AAS使用者;n = 16名对照组)。在AAS使用者的AAS周期前(Pre)、周期中(During)和周期后6 - 8周(Post)测量收缩压和舒张压、RPP、静息心率和身体成分,对照组在相似的时间间隔进行测量。在整个研究过程中,对照组未发现明显的心血管或形态学变化。AAS组从周期前到周期后,舒张压(P<0.01)和平均动脉压均显著升高(P<0.05)。AAS周期前后,RPP也显著升高(P<0.01)。所有心血管参数在周期后6至8周恢复到正常基线测量值。在整个研究过程中,没有血压测量值符合临床定义的高血压。研究结果表明,与对照健美运动员相比,AAS组的标准心血管测量值显著增加,这为使用AAS提供了一个禁忌证,尤其是在临界高血压患者中。